Fundraising FoxMerge Bio Therapeutics
Cambridge, US · Founded 2025 · Delaware corporation · 1 known investors
Find your way into Merge Bio Therapeutics
Sign up to see every warm intro you have to Merge Bio Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Merge Bio Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
CH
Clinton HansenExecutive
WW
Wesley WongNamed on SEC filing
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$5M disclosed across 1 round · 2025
▶$5MraisedSep 2025 · 1 investors · OtherRule 506(b)
▶$5MraisedSep 2025 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Mark LipsteinPromoter
- Steve LiapisDirector
- Clinton HansenExecutive Officer, Promoter
- Elias QuijanoDirector
- Wesley WongExecutive Officer, Director, Promoter
- Darren YangPromoter
- Offering amount
- $15M
- Amount sold
- $5M
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Merge Bio Therapeutics's investors?
- Merge Bio Therapeutics's investors include Northpond Ventures.
- How much funding has Merge Bio Therapeutics raised?
- Merge Bio Therapeutics has disclosed $5M raised across 1 round.
- Where is Merge Bio Therapeutics headquartered?
- Merge Bio Therapeutics is headquartered in Cambridge, US.